The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
T-LAK cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in ovarian cancer.
 
Yuji Ikeda
No Relationships to Disclose
 
Jae Hyun Park
Consulting or Advisory Role - OncoTherapy Science
 
Takashi Miyamoto
Employment - OncoTherapy Science
 
Naofumi Takamatsu
Employment - OncoTherapy Science
 
Akiko Iwasa
No Relationships to Disclose
 
Shuhei Okabe
Employment - OncoTherapy Science
 
Yuichi Imai
No Relationships to Disclose
 
Keiichi Fujiwara
Honoraria - Chugai Pharma; Eisai; Kyowa Hakko Kirin; Nippon Kayaku; Taiho Pharmaceutical; Yakult Honsha; Zeria Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; MSD; Pfizer
Research Funding - Chugai Pharma (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Johnson & Johnson (Inst); Kaken Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Yusuke Nakamura
Stock and Other Ownership Interests - OncoTherapy Science
Consulting or Advisory Role - OncoTherapy Science
Research Funding - OncoTherapy Science
Patents, Royalties, Other Intellectual Property - OncoTherapy Science
 
Kosei Hasegawa
Honoraria - Chugai Pharma; Ono Pharmaceutical
Consulting or Advisory Role - ImmunoGen